cules that are involved in the regulation of many cellu-lar processes, including those related to human can-cers. The aim of this study was to determine, as a proof of principle, whether specific candidate miRNAs could be detected in fine-needle aspirate (FNA) biopsies of pancreatic ductal adenocarcinoma (PDAC) and could accurately differentiatemalignant frombenign pancre-atic tissues. METHODS: We used TaqMan ® assays to quantify miRNA levels in FNA samples collected in RNARetain (n 16) and compared the results with a training set consisting of frozenmicrodissected pancreatic samples (n 20). RESULTS: Quantitative reverse-transcription PCR anal-ysis confirmed thatmiRNA levels are affected in PDAC FNAs and correlate well with the changes ob...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers worldwide, partly because m...
Background MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, there...
microRNAs (miRNAs) have been reported to be aberrantly expressed in patients with pancreatic cancer....
A solid process for diagnosis could have a substantial impact on the successful treatment of pancrea...
<div><p>A solid process for diagnosis could have a substantial impact on the successful treatment of...
Ductal adenocarcinoma (PDAC) is the most common primary pancreatic neoplasm. It's frequently diagnos...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...
Pancreatic ductal adenocarcinoma (PDAC), a rare but lethal tumor, is difficult to diagnose without p...
MicroRNAs (miRNAs) are reportedly involved in pancreatic ductal adenocarcinoma (PDAC) development. C...
Background: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease. Novel biomarkers are requir...
MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC),...
Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common type of PCa with 2-9% 5-year ...
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most aggressive malignancies and ha...
Context While global microRNA ( miRNA) expression patterns of many embryologic, physiologic, and onc...
Introduction: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rat...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers worldwide, partly because m...
Background MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, there...
microRNAs (miRNAs) have been reported to be aberrantly expressed in patients with pancreatic cancer....
A solid process for diagnosis could have a substantial impact on the successful treatment of pancrea...
<div><p>A solid process for diagnosis could have a substantial impact on the successful treatment of...
Ductal adenocarcinoma (PDAC) is the most common primary pancreatic neoplasm. It's frequently diagnos...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...
Pancreatic ductal adenocarcinoma (PDAC), a rare but lethal tumor, is difficult to diagnose without p...
MicroRNAs (miRNAs) are reportedly involved in pancreatic ductal adenocarcinoma (PDAC) development. C...
Background: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease. Novel biomarkers are requir...
MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC),...
Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common type of PCa with 2-9% 5-year ...
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most aggressive malignancies and ha...
Context While global microRNA ( miRNA) expression patterns of many embryologic, physiologic, and onc...
Introduction: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rat...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers worldwide, partly because m...
Background MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, there...
microRNAs (miRNAs) have been reported to be aberrantly expressed in patients with pancreatic cancer....